These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Health-related quality of life in patients with haemophilia and inhibitors on prophylaxis with anti-inhibitor complex concentrate: results from the Pro-FEIBA study. Gringeri A, Leissinger C, Cortesi PA, Jo H, Fusco F, Riva S, Antmen B, Berntorp E, Biasoli C, Carpenter S, Kavakli K, Morfini M, Négrier C, Rocino A, Schramm W, Windyga J, Zülfikar B, Mantovani LG. Haemophilia; 2013 Sep; 19(5):736-43. PubMed ID: 23731246 [Abstract] [Full Text] [Related]
6. Measurement properties of the Haem-A-QoL in haemophilia clinical trials. von Mackensen S, Eldar-Lissai A, Auguste P, Krishnan S, von Maltzahn R, Yu R, Wyrwich KW. Haemophilia; 2017 May; 23(3):383-391. PubMed ID: 28026074 [Abstract] [Full Text] [Related]
7. The impact of severe haemophilia and the presence of target joints on health-related quality-of-life. O'Hara J, Walsh S, Camp C, Mazza G, Carroll L, Hoxer C, Wilkinson L. Health Qual Life Outcomes; 2018 May 02; 16(1):84. PubMed ID: 29720192 [Abstract] [Full Text] [Related]
8. Patient-reported outcomes and joint status across subgroups of US adults with hemophilia with varying characteristics: Results from the Pain, Functional Impairment, and Quality of Life (P-FiQ) study. Batt K, Boggio L, Neff A, Buckner TW, Wang M, Quon D, Witkop M, Recht M, Kessler C, Iyer NN, Cooper DL. Eur J Haematol; 2018 Apr 02; 100 Suppl 1():14-24. PubMed ID: 29498783 [Abstract] [Full Text] [Related]
9. Health-related quality of life as outcome parameter in haemophilia treatment. Fischer K, van der Bom JG, van den Berg HM. Haemophilia; 2003 May 02; 9 Suppl 1():75-81; discussion 82. PubMed ID: 12709041 [Abstract] [Full Text] [Related]
10. Health-related quality of life and health status in adolescent and adult people with haemophilia A without factor VIII inhibitors-A non-interventional study. Oldenburg J, Tran H, Peyvandi F, Núñez R, Trask P, Chebon S, Mahlangu JN, Lehle M, Jiménez-Yuste V, von Mackensen S. Haemophilia; 2021 May 02; 27(3):398-407. PubMed ID: 33576546 [Abstract] [Full Text] [Related]
11. No difference in quality of life between persons with severe haemophilia A and B. Kihlberg K, Baghaei F, Bruzelius M, Funding E, Andre Holme P, Lassila R, Nummi V, Ranta S, Gretenkort Andersson N, Berntorp E, Astermark J. Haemophilia; 2023 Jul 02; 29(4):987-996. PubMed ID: 36791275 [Abstract] [Full Text] [Related]
12. Health-related quality of life and health status in persons with haemophilia A with inhibitors: A prospective, multicentre, non-interventional study (NIS). Mahlangu J, Oldenburg J, Callaghan MU, Shima M, Mancuso ME, Trask P, Recht M, Garcia C, Yang R, Lehle M, Macharia H, Asikanius E, Levy GG, Kruse-Jarres R, von Mackensen S. Haemophilia; 2019 May 02; 25(3):382-391. PubMed ID: 31016855 [Abstract] [Full Text] [Related]
14. A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis. Salaffi F, Carotti M, Ciapetti A, Gasparini S, Grassi W. Clin Exp Rheumatol; 2011 May 02; 29(4):661-71. PubMed ID: 21813061 [Abstract] [Full Text] [Related]
15. Real-world comparative analysis of bleeding complications and health-related quality of life in patients with haemophilia A and haemophilia B. Booth J, Oladapo A, Walsh S, O'Hara J, Carroll L, Garcia Diego DA, O'Mahony B. Haemophilia; 2018 Sep 02; 24(5):e322-e327. PubMed ID: 30091822 [Abstract] [Full Text] [Related]
16. Health-related quality of life and physical activity in Nordic patients with moderate haemophilia A and B (the MoHem study). Måseide RJ, Berntorp E, Astermark J, Olsson A, Bruzelius M, Frisk T, Nummi V, Lassila R, Tjønnfjord GE, Holme PA. Haemophilia; 2024 Jan 02; 30(1):98-105. PubMed ID: 37983883 [Abstract] [Full Text] [Related]
17. Quality of life is associated to the orthopaedic status in haemophilic patients with inhibitors. Scalone L, Mantovani LG, Mannucci PM, Gringeri A, COCIS Study Investigators. Haemophilia; 2006 Mar 02; 12(2):154-62. PubMed ID: 16476090 [Abstract] [Full Text] [Related]
18. Social/economic costs and quality of life in patients with haemophilia in Europe. Cavazza M, Kodra Y, Armeni P, De Santis M, López-Bastida J, Linertová R, Oliva-Moreno J, Serrano-Aguilar P, Posada-de-la-Paz M, Taruscio D, Schieppati A, Iskrov G, Gulácsi L, von der Schulenburg JM, Kanavos P, Chevreul K, Persson U, Fattore G, BURQOL-RD Research Network. Eur J Health Econ; 2016 Apr 02; 17 Suppl 1():53-65. PubMed ID: 27048374 [Abstract] [Full Text] [Related]
20. The relative burden of haemophilia A and the impact of target joint development on health-related quality of life: results from the ADVATE Post-Authorization Safety Surveillance (PASS) study. Klamroth R, Pollmann H, Hermans C, Faradji A, Yarlas AS, Epstein JD, Ewenstein BM. Haemophilia; 2011 May 02; 17(3):412-21. PubMed ID: 21332888 [Abstract] [Full Text] [Related] Page: [Next] [New Search]